Papillary Thyroid Carcinoma: Clinical Trials

1 trial for Papillary Thyroid Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow Papillary Thyroid Carcinoma: new trials by email Literature Review of Papillary Thyroid Carcinoma trials Research Report on Papillary Thyroid Carcinoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)
Sacituzumab Tirumotecan - Recurrent Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma Metastatic
Phase 2Not yet recruitingNational Cancer Centre, Singapore682026-11-012026-07-15

Narrower conditions

Carcinoma, Adenoid Cystic (1)  ·  Neoplasm Metastasis (1)  ·  Recurrence (1)  ·  Thyroid Cancer, Papillary (1)

Broader conditions

Adenocarcinoma (1)  ·  Adenocarcinoma, Papillary (1)  ·  Carcinoma (1)  ·  Disease Attributes (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Head and Neck Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Thyroid Diseases (1)

Sponsors

National Cancer Centre, Singapore (1)

Countries

Japan (1)  ·  Malaysia (1)  ·  Singapore (1)  ·  South Korea (1)

Top investigators

Darren Wan-Teck Lim, MBBS (S'pore), MRCP (UK), FAMS (1)